---
{"dg-publish":true,"permalink":"/USMLE/Renal/Benign prostatic hyperplasia/"}
---

# Epidemiology


---
# Etiology
- Dihydrotestosterone (DHT) is a potent prostatic growth factor.
- Androgen-estrogen imbalance: As men age, testosterone levels decline, but estrogen levels remain the same, which results in a higher estrogen/testosterone ratio.

---
# Pathophysiology


---
# Clinical features


---
# Diagnostics
## Serum [[USMLE/Renal/Prostate-specific antigen\|PSA]] level
- Findings
	- Total [[USMLE/Renal/Prostate-specific antigen\|PSA]] > 1.5 ng/mL: suggests an enlarged prostate (> 40 mL) 
	- Total [[USMLE/Renal/Prostate-specific antigen\|PSA]] > 4 ng/mL: increased likelihood of [[USMLE/Renal/Prostate cancer\|prostate cancer]]
- Free PSA levels and free PSA/total PSA ratio
	- ↑ Free PSA levels and ↑ free PSA/total PSA ratio: usually seen in BPH
	- ↓ Free PSA levels and ↓ free PSA/total PSA ratio: suggestive of [[USMLE/Renal/Prostate cancer\|prostate cancer]]
## MRI and CT pelvis
![Pasted image 20241122150113.png](/img/user/appendix/Pasted%20image%2020241122150113.png)

---
# Treatment
## Pharmacological therapy
### Uroselective alpha-1 blockers
- Tamsulosin, Doxazosin, Alfuzosin, Terazosin
### 5-alpha reductase inhibitors (5-ARIs)
- See [[USMLE/Reproductive/Androgen and estrogen synthesis#Adrenal androgen synthesis\|Androgen and estrogen synthesis#Adrenal androgen synthesis]]
- Inhibition of 5-alpha reductase → ↓ conversion of testosterone to DHT → ↓ intraprostatic DHT levels → ↓ prostatic growth and ↑ prostatic apoptosis and involution → improvement of LUTS![Pasted image 20230925162608.png](/img/user/appendix/Pasted%20image%2020230925162608.png)
- Adverse effects: sexual dysfunction (e.g., erectile dysfunction, decreased libido, ejaculatory dysfunction), gynecomastia
- Finasteride, Dutasteride
>[!tip] 
>-steride (“testosterone reductase inhibitor”)
### Phosphodiesterase type 5 inhibitors (PDE-5 inhibitors)
- <span style="background:rgba(240, 200, 0, 0.2)">Increase in intracellular [[USMLE/Biochemistry/Signal transduction\|cGMP]] → ↓ detrusor, prostate, and urethra muscle tone → improvement of LUTS</span>
- <span style="background:rgba(240, 200, 0, 0.2)">Tadalafil</span>

---
# Complications
- Recurrent [[USMLE/Renal/Urinary tract infections\|UTI]] 
	- BPH → incomplete voiding → urinary stasis → predisposition to [[USMLE/Renal/Urinary tract infections\|UTIs]]
- Urinary retention with bladder distension and bladder wall thickening (hypertrophy)
- Bladder calculi
- <span style="background:rgba(240, 200, 0, 0.2)">Hydronephrosis</span>
- [[USMLE/Renal/Chronic kidney disease\|Chronic kidney disease]]
